Dentsu Group - FY24 prospects weighted to H2
Dentsu’s Q1 results indicate a slow start to the year, with organic net revenue down by 3.7%. However, prospects are improving, buoyed by new...
213 Views
Basilea Pharmaceutica - Cresemba milestone payments continue to roll in
Basilea Pharmaceutica has announced the triggering of a US$1.25m milestone payment from Pfizer, triggered by sustained strong sales of Cresemba in...
185 Views
Record - AUME momentum and a sharper focus
Record’s Q424 trading update demonstrated continued growth in assets under management equivalent (AUME), which will support management fee growth...
104 Views
Actinogen Medical - Funding in place through key catalysts
Actinogen announced a capital increase of up to A$8.9m on 3 May, consisting of a A$5.0m (gross) placement along with a shareholder rights offering...
159 Views
Finsbury Growth & Income Trust - Train puts his money where his mouth is
Finsbury Growth & Income Trust (FGT) has been managed by Lindsell Train since the beginning of 2001. During his long tenure, approaching a...
148 Views